Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Key facts
- Where
- Boston, Charlottesville, Cleveland, Los Angeles, Philadelphia, Portland, Rochester, and Salt Lake City, United StatesSee the 8 sites
Where in United States
- Boston University School of MedicineBoston, United StatesNo longer taking part
- University of VirginiaCharlottesville, United StatesTaking people
- Cleveland ClinicCleveland, United StatesNo longer taking part
- University of California, Los AngelesLos Angeles, United StatesNo longer taking part
- University of PennsylvaniaPhiladelphia, United StatesTaking people
- Oregon Health Science UniversityPortland, United StatesNo longer taking part
- Mayo ClinicRochester, United StatesNo longer taking part
- University of UtahSalt Lake City, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peter Merkel
- Trial code
- NCT03004326
- Record updated
- 22 January 2026
- Original description
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.Read full original descriptionShow less
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Inclusion: Have a cutaneous lesion (purpuric macules, palpable purpura, retiform purpura, nodules, ulcers, or urticarial) believed to be related to active vasculitis; Have a suspected or confirmed diagnosis of:; Cryoglobulinemic vasculitis (CV); Drug-induced vasculitis; Eosinophilic granulomatosis with polyangiitis (EGPA); IgA vasculitis; Isolated cutaneous vasculitis; Granulomatosis with polyangiitis (GPA); Microscopic polyangiitis (MPA); Polyarteritis nodosa (PAN); Urticarial vasculitis; Be willing and able to provide written informed consent (or assent for those under.
Exclusion: Considered not to be a candidate for a biopsy or have a higher risk of developing an infection, bleeding, etc., from the biopsy, or a doctor believes that the risks for you participating in this study do not outweigh the potential benefit of learning information from your biopsy; You have an uncontrolled disease that could prevent you from completing the study procedures; You have an active infection at or near the potential biopsy site, have poor circulation, or have bony prominence or other structure that would increase your risk of complications if you participated in this study; You have a neutrophil count (type of white blood cell) less than 1500/mm3, platelet count less than 50,000/mm3, or a hemoglobin less than 7 g/dL; You are less than five years old; You are pregnant or nursing; You are not able to provide informed consent.